Full Transcript Introduction and guest background 0:00 Hi and welcome to another episode of the Healing Lyme Summit. 0:03 I'm your host, Doctor Myriah Hinchey. 0:05 And today we're going to be talking about cerebral folate deficiency. 0:09 And it's possible links with Lyme and other co-infections. 0:13 So here with me today is one of my great friends 0:17 and fellow naturopathic doctors, Doctor Lindsey Wells. 0:21 Doctor Wells is the lead author on the recent publication 0:25 on Foley receptor alpha antibodies in the pediatric Acute 0:29 Onset Neuropsychiatric Syndrome, or Pans and Pandas. 0:34 She's also the co-founder of Lyme Heal Hers, which is an online summit 0:38 focused on women and children suffering from vector borne diseases, 0:42 as well as one of the first naturopathic physicians to receive their fellowship 0:47 from the Medical Academy of Pediatric Special Needs, or Maps. 0:51 For more information on maps, you can go to Med maps.org. 0:55 So welcome Doctor Wells. 0:57 It is an honor and a privilege to have you here with me. 1:00 Tell our listeners 1:01 a little bit more about yourself and how you came to specialize 1:06 in pediatrics and vector borne disease, and how you ended up 1:10 being involved in and leading this study on cerebral folate deficiency. 1:15 Well, thank you so much for having me. 1:17 So as you said, I'm a naturopathy doctor. 1:19 I practice in Trumbull, Connecticut, and I knew early on 1:24 in my career that I wanted to work with the pediatric population. 1:27 My heart was really with children with neurodevelopmental disorders like autism. 1:32 I just find them to be 1:35 so lovely to work with. 1:36 And their families are amazing. 1:38 And so I spent a lot of time working with children with autism. 1:41 And then that kind of shifted into working mainly with children with pans, pandas. 1:47 And so early on in my career with Pans Pandas, you were seeing a lot of, 1:51 for instance, strep causing the onset or a mycoplasma, 1:55 and then what ended up happening was 1:59 I was seeing cases that were getting harder 2:01 and harder to treat, and there wasn't that waxing 2:04 and waning presentation that we usually see around an infection. 2:08 What we were seeing is that these kids were in what I call 2:11 constant flares, meaning that every day 2:14 was pretty difficult for that child with some neuropsychiatric symptoms, 2:17 whether that was separation anxiety, OCD, 2:21 behavioral regressions, academic decline. 2:25 And it was getting really challenging for the children and the family members. 2:29 And so we had to start exploring deeper, like what was going on with these kids. 2:34 And what we were finding was it was almost disturbing 2:37 the findings of vector borne diseases with these kids with pans and pandas. 2:42 And so it was mainly Bartonella that was coming up, which really 2:46 made sense in regards to the neuro psych symptoms with these children, especially, 2:50 like the rage and the aggression and the anxiety and the OCD. 2:55 But what's really also come recently, in the past few years, 2:58 is also bbca coming up right behind Bartonella in my population. 3:03 So that's kind of how I got into this was like just exploring 3:07 deeper of like, what are these children suffering from 3:09 and why are they like chronically having these flares and finding 3:13 that the majority of them do have vector borne diseases. 3:16 So I had to, you know, learn how to manage those infections. 3:20 And what was beautiful is seeing that these children 3:22 and these families started to get relief because we found out 3:25 what the infection was underneath that were contributing 3:28 to the immune burden for them to be presenting with the symptoms. 3:32 So that's how I got into this field, and I feel very grateful 3:37 and excited about it, that I can offer hope and answers 3:41 to families who are experiencing this with their child. 3:45 Yeah, and we are very grateful to have you 3:48 and all the work that you're doing and really like at large. 3:51 This community is very lucky to have someone like you. 3:54 That does not stop digging at the root cause, right? 3:58 Because, you know, for a lot of people it's like, oh, pans, pandas, there it is. 4:02 That's the root. 4:02 And it's like, no, there's always something deeper causing 4:06 that immune dysfunction that actually allows 4:10 for pans or Pandas to occur. 4:13 What are they? 4:14 All right. 4:15 So today though we're going to focus on cerebral folate deficiency 4:19 and the role that it plays. 4:20 And for listeners that don't know it plays a role in autism spectrum disorder. 4:25 It plays a role in Pans and Pandas a lot of times. 4:29 And also, you know, it plays a role in a lot of neuro 4:33 degenerative as well as neuro psychiatric issues. 4:36 So even beyond what we're talking about, just to get it on the radar, 4:40 it's implicated in depression and anxiety. 4:43 Can be with Parkinson's can be and dementia stroke like there's
What cerebral folate deficiency is 4:48 there's just a much wider array of issues that it can cause here. 4:53 But doctor, well, start out by telling us exactly what it is. 4:57 So cerebral folate deficiency essentially 4:59 is just not getting enough folate into the brain so fully. 5:03 We've probably heard about this nutrient, right. 5:05 Being very important when, a woman is pregnant to decrease neural tube defects. 5:10 Correct. 5:11 Can also be helpful for anemia. 5:14 But what people don't realize is that we actually need folate 5:18 in our brain to help with regulating neurotransmitters, to help 5:23 with doing methylation, different pathways to help with detoxification. 5:27 And when we don't get enough folate into the brain, there can be consequences. 5:31 Many of the things that you just, you know, mentioned on top of also seizures, 5:36 schizophrenia, and then the biggest one is neurodevelopmental delays and autism. 5:41 But treatment resistant depression, 5:44 dementia there's many different as I said consequences are manifestation 5:49 two cerebral folate deficiency just not getting enough 5:52 folate into the brain. 5:54 And what's very interesting is 5:55 you can have normal levels of folate in your blood. 5:58 So say you test your blood just for folate and you're like, there's plenty there. 6:03 But the levels look good. 6:04 I must not have an issue. 6:06 You can still have an issue and have cerebral folate deficiency 6:11 because of particularly many different reasons. 6:14 But particularly what we're going to talk about 6:15 is the auto antibodies not being able to shuttle 6:18 that folate into the brain, leading to the cerebral folate deficiency. 6:23 Right. 6:23 So you can have plenty of folate in the body. 6:26 And obviously there are various forms of folate which we'll talk about. 6:30 But for everyone listening, you know, it's 6:32 not enough just to have a nutrient or a substance in the body. 6:35 It has to be able to get to and bind to the receptor to actually bring 6:41 about the physiological change or action that we're looking for. 6:46 From that nutrient. 6:47 So why don't you tell us, tell us a little bit about the different 6:50 forms of Foley and tell us about the receptors 6:54 and how like what is the like Pappu physiology behind how this arises. 6:59 So this is very like a simplistic kind of pathway that I'm going to talk about. 7:04 But essentially 7:05 we get folate from things in our diet especially like green leafy vegetables. 7:09 That has to be converted in such a way that it can become bioactive, 7:14 that the body can recognize it and plug it into its pathway. 7:17 So it's going to go from folate to phonic acid to methyl tetrahedra, 7:22 folate that methyl tetrahedral folate is the bioactive form 7:26 of folate that again, the body can utilize in its pathways. 7:30 And so when we're talking specifically at the brain, the brain 7:34 at the blood brain barrier is a very tightly regulated system. 7:38 And we're very fortunate for that. Right. 7:40 So not anything can just enter into the brain. 7:43 But at the brain there's going to be receptors. 7:45 And I think of these as locks. 7:47 And they have a specific key that can bind into it to be brought into the brain. 7:52 So there are receptors on the blood brain barrier for this 7:55 methyl tetrahedral folate that methyl tetrahedra. 7:58 Folate is the key. 7:59 It can bind into that receptor and then be brought into the brain 8:03 to go through those many different processes that I discussed previously. 8:07 But what can happen is that there can be abnormalities at that receptor site 8:13 where there is actual auto antibodies that block the receptors 8:18 that don't allow the methyl folate to get into the brain. 8:22 So essentially what happens then? 8:24 That's when you have this cerebral folate deficiency and then may have 8:28 those symptoms that we mentioned before. 8:32 So someone could even be taking methyl folate. 8:35 But if you do not resolve the issues that are binding or blocking 8:40 to the receptor and inhibiting the Foley, the methyl folate from attaching 8:45 like the key to the lock, then you're still going to have the issue. 8:49 Absolutely. 8:50 So a lot of people will say, well, I have the mgmt for mutation. 8:54 And so I'm taking methyl folate. 8:55 So I should be good right. 8:57 That's not the case because when you have these autoantibodies 9:01 there's two types in particular that we focus on or test for. 9:05 One is blocking where the antibody literally blocks the receptor. 9:09 So no methyl folate combine to it. 9:11 So it doesn't matter how much methyl folate you're taking. 9:14 On the other side there's something called the binding autoantibody. 9:19 And that can bind to anywhere on the receptor and essentially alter its shape. 9:23 So it doesn't function optimally. 9:26 So you can't get enough in. 9:28 So really, what's interesting and what the research has found 9:32 is that you essentially need to flood the system with the linick acid, 9:37 which is a step above methyl tetra, hydrophobic eight to access a different 9:42 carrier transport system in the brain 9:46 to then bring in the clinic acid. 9:48 How that works. 9:49 But then there's another piece to it too, right? 9:52 Because that wouldn't be enough. 9:54 So tell us about the molecular mimicry with dairy 9:58 and how dairy is actually one of these underlying like root causes 10:04 of of how this would even occur in the first place. 10:07 So there's two ways that some that we know of that 10:10 somebody could have cerebral folate deficiency.
Folate receptors, autoantibodies, and dairy triggers 10:13 One is a non-genetic hereditary type of process that occurs. 10:18 So this is something that somebody possibly could be born with. 10:22 Right. 10:23 And what we see is that there is some like mothers and fathers can have this 10:27 and siblings can have it 10:28 even if they don't have the manifestations from it. 10:31 The other piece is that we can get this from consuming dairy products. 10:36 And this is all animal dairy. 10:39 You know, most of the research is just with cow dairy, but 10:41 we can kind of make the assumption that it's all animal dairy. 10:45 So what happens is molecular mimicry that with cow dairy, what we know is, 10:51 is that the folate receptor autoantibodies, those antigens are about 10:56 90% like homologous to what we have in the antigens in our body. 11:01 And so when we consume the dairy what happens is our intestinal 11:05 our intestines will actually make those autoantibodies itself. 11:10 And so when we're drinking the milk or taking the dairy product, 11:15 we're just essentially causing our body to make more of those autoantibodies. 11:21 And then what that's doing is it's blocking the receptors on the brain. 11:26 And so 11:26 one of the biggest treatments besides giving high dose for clinic acid, 11:31 is removing all animal dairy from the diet completely. 11:36 And it's so interesting. 11:38 There's been some research 11:39 not much, but looking at this to see how the autoantibody levels 11:44 drop significantly once somebody takes dairy out of their diet, 11:48 even when you're not giving high dose full and a gas at 11:51 the high dose one a acid essentially just giving your brain 11:55 the folate that it needs, right. 11:56 But in order to bring down 11:58 the autoantibodies, you have to remove the dairy. 12:01 And then when you reintroduce the dairy, how it almost skyrockets. 12:06 Again, those those folate receptor autoantibodies. 12:09 So that's a very important piece of the puzzle 12:11 because a lot of times when people want to, you know, go through treatment, 12:15 it's much easier to take a pill of phonic 12:19 acid than it is to modify their diet. 12:22 But it's almost like you might get some relief from it, and you probably will, 12:27 just not to the extent that you could find relief from symptoms 12:31 and really long term treatment as the two of them together. 12:34 The removal of animal dairy and also implementing, high dose phonic acid. 12:40 Right. 12:40 And it's almost like, you know, this 12:42 this can be reversible if you do both things together. 12:47 It might not be reversible to the point 12:49 that you can eat dairy again, but you can resolve the issue 12:53 by taking high dose splenic acid and avoiding all dairy products. 12:57 I just want to make one point to our listeners. 13:00 So this is not something where you would go 13:04 and have a food sensitivity test, like looking at IgG or IGA. 13:08 This is not something where you would go to an allergist and have an IGI 13:12 towards dairy, or casein or whey, or any component of animal dairy. 13:17 This is something completely different where the immune system gets triggered 13:22 and confused because of the dairy and makes these autoantibodies. 13:27 So I just want it to be clear. 13:29 If you've had dairy ruled out, you know, as an allergy, 13:33 that has nothing to do with what we're talking about. 13:35 Absolutely correct about that, because you're not looking for antigen 13:40 antigen or the immunoglobulins against dairy. 13:43 You're looking for folate receptor autoantibodies. 13:47 So they're completely separate. 13:48 And you can have somebody 13:49 that does not have a sensitivity does not have an allergy to dairy. 13:53 But yet they are very positive for the full receptor autoantibodies 13:57 or vice versa. 13:58 Somebody who is sensitive to dairy or allergic to dairy 14:01 and they don't have the autoantibodies against the receptor. 14:04 So therefore they do not have cerebral folate deficiency. 14:08 And that's also that's a great point. 14:10 And another thing I want to bring up is 14:12 and just kind of reiterate is the same thing with the Antifa 14:16 mutation, I feel like a lot of people get hung up on that thinking, 14:19 okay, well, if I have MTX for I have cerebral folate deficiency. 14:23 They are two completely separate things here. 14:26 The MTA. 14:26 GFR is a genetic mutation that you're not able to, you know, 14:30 convert your full weight to the bioactive form as well as you should be. 14:34 So there you have a harder time going from folate to the methyl tetra hydrophobic 14:40 when the cerebral folate deficiency is just 14:42 because one of the biggest reasons is those autoantibodies. 14:46 And you can have autoantibodies without having MTX, 14:49 or you can have MT AFA without having cerebral folate deficiency. 14:53 So that's a very common question that I get as well or an assumption 14:57 that people make. 14:58 I must have that too, because, you know, or my child must have that 15:01 because they haven't cfAa. 15:03 It's it's completely separate, right. 15:06 So before we move on to talking about potential links 15:09 between really severe neuropsychiatric symptoms in Lyme 15:14 and the possible connection, tell me a little bit more about, 15:18 I want to talk about why treating with clinic acid 15:21 is more important than using methyl folate. 15:25 And then also I want to talk about testing for these autoantibodies. 15:30 So the 15:30 research for cerebral folate deficiency is really done 15:33 with Luca Vaughan which is a clinic acid medication. 15:37 And so that's where we have the majority of our research. 15:40 But also clinically we see much better 15:43 outcomes using clinic than we will with methyl tetra hydro folate. 15:47 So for clinic acid, when you use high dose for clinic acid 15:50 it has been shown to allow for the reduced folate carrier. 15:55 So it's a different carrier that's on the blood brain 15:58 barrier to shuttle in the folate. 16:01 So essentially that one gets activated when there's high extracellular. 16:06 So a lot of folic acid in the system to move it in. 16:11 We don't have as much evidence that that occurs with methyl tetrahedra folate. 16:16 And so I think there's only been like one study Urso 16:19 that has shown that you could have the same effects. 16:23 But again, clinically in my practice I have many children 16:27 and adults with cerebral folate deficiency. 16:30 And we always see more resolution in their symptoms by using 16:34 the high dose phonic acid. 16:38 Okay. 16:38 Great. 16:39 And so now if someone wants to get tested to see if they have 16:43 this autoantibody process causing cerebral folate deficiency, 16:48 what testing do you recommend and explain the testing a little bit more? 16:51 The company in the lab name is religion. 16:54 And you can go online at frat now.com to find information about the test. 17:00 To find information about how to order a kit, you likely will need, physician 17:05 name in order to get a kit, but you can inquire with them. 17:08 I think they also have a list of providers as well. 17:11 So the providers who are ordering this test, 17:14 if maybe you want to establish care for them, for yourself, for your child. 17:17 And what I also love about their website is they have a lot of the research 17:21 out on cerebral folate deficiency. 17:23 So if you do love to read the research, 17:26 you can kind of find it all in one place there. 17:28 Are there any prevalence numbers in the 17:31 in the Lyme community as far as like the prevalence? 17:35 I haven't seen any studies, but I know that you look 17:39 at those very closely with with your patient population. 17:44 Yes. So there is no research out right now in regards 17:47 to cerebral for a deficiency in tick borne disease or vector borne diseases. 17:52 And this is something that I'm very passionate about as I know you are too. 17:56 And I've been scrubbing my own data. 17:58 And the data actually looks very promising that about 50% of people who have 18:03 vector borne diseases are also positive for the cerebral folate deficiency. 18:07 This is obviously pre published, but it's, 18:10 you know, part of my mission to get this out, this information out. 18:14 And so I'm still pulling that and going to explore a little bit further. 18:18 Of the ones who are positive, what symptoms are they manifesting. 18:23 Because my suspicion is these are patients who have tick borne diseases 18:28 and are experiencing neuropsychiatric symptoms from the vector borne disease. 18:32 So whether that's, you know, significant depression, anxiety, OCD, brain fog,
Testing, prevalence, and links to Lyme and PANS/PANDAS 18:38 memory loss like dementia type symptoms, bipolar type symptoms. 18:43 Like this is what my suspicion is. 18:45 So but the prevalence looks very interesting here. 18:50 And so hopefully I'll have that you know 18:53 yeah. 18:54 Partner with me Maria to do that. 18:55 And we'll get that information out. 18:57 Yeah I would love to. 18:58 I'm as you know fascinated in the same area. 19:01 And yes hopefully by the time you know this is airing in April, 19:06 we will be way underway to have those answers to share 19:10 with all of you listening, because it really would be fascinating. 19:13 There is a lot of this vector borne disease patient population that have way 19:19 more neuropsychiatric and cognitive issues than they do musculoskeletal. 19:25 And again, it would be so interesting to see 19:27 if this is part of what's playing that role. 19:29 Okay. 19:30 So let's transition into talking about treatment. 19:33 So obviously we've alluded to you know using high dose 19:37 splenic acid and removing dairy from the diet. 19:40 What else do you look at when you are treating 19:45 patients that have cerebral folate deficiency. 19:50 You know it's a great question. 19:52 You know I will look at some other markers too. 19:54 Like looking at other B vitamins. I'll look at their blood cell count. 19:57 So liver and kidney function, their mitochondrial markers. 20:00 But really the big treatment here is doing 20:04 the high dose full intake acid and removing the dairy. 20:07 And just that in general brings down a significant amount of inflammation. 20:11 Actually it helps improve their detoxification pathways. 20:15 And it also makes their treat like the other treatment 20:19 that they're doing more effective. 20:21 And we see this actually in the treatment resistant depression population 20:26 where there's studies are ranging from 20:29 about a third to over a half of patients who have treatment 20:33 resistant depression have cerebral folate deficiency. 20:36 And when high dose formic acid is added to their treatment plan, 20:41 they are finding it finding moderate to significant 20:46 relief in their symptoms when added with their psychiatric 20:49 medication that they were taking. 20:52 And so that's I also I'm finding that in my practice with people 20:56 not necessarily using psychiatric medications, 20:58 but with them just going through treatment, 21:01 right of antimicrobials, more immune support, anti-inflammatories. 21:06 And it's like we're seeing more improvements in their symptoms 21:10 adding in this piece than we are, you know, with not having it end. 21:15 Yeah. 21:16 And you know, it's important to talk about two I think I think 21:19 sometimes the level of anxiety is literally debilitating. 21:23 So it's like it's hard for these patients to even be able 21:27 to follow any simplistic treatment protocol. 21:31 Not that, you know, treatment for vector borne disease is all that simple. 21:34 But I mean, it makes it very, very hard for them to carry out their their daily 21:39 living tasks and so when you can bring down the level 21:43 of anxiety or the level of confusion, you know, just those two things alone, 21:48 it actually enables patients to then be able to look at the bigger picture 21:53 and do a lot of like the dietary interventions and expanded 21:58 protocols that it takes to really heal the body from Lyme and co-infections. 22:02 A couple questions. 22:03 So when you say high dose full anycast at what does that mean? 22:07 Because the typical supplement on the market 22:10 is 800 micrograms. 22:13 Right? Right. What are we talking. 22:16 The high dose in the literature is 2mg/kg 22:21 up to 50mg per day. 22:23 So we're talking 50mg 22:26 for most people even even children. 22:29 You know who it's significant at 2mg/kg. 22:33 And it's kind of surprising when you have, 22:35 you know, a five year old in your office. 22:37 And they need to be up to 50mg. 22:39 But yet you then have to tell them they have to take, you know, 22:43 to almost two bottles of 22:46 what's available on the market per day. 22:49 Oh, yeah. Sorry. Per day. Yes, per day. 22:52 I had I had a parent for a less than two year old crushing 15 22:57 tabs. 22:58 Yes, twice a day. 23:00 Yes. And they were I think their, 23:03 their supplement was costing them around $600 a month. 23:07 Right. Just to take that. Yes. 23:09 And so there is a pharmaceutical available on the market. 23:13 It's called Luca foreign and Luca Veran, can be prescribed by physicians. 23:18 What I find is that it's very challenging to find a physician to prescribe this, 23:23 because Luca born is classified 23:25 as a chemotherapy drug because it's a rescue for chemotherapy. 23:29 It helps to replete the full Anik acid and the folate 23:32 that's essentially depleted from going through chemotherapy. 23:35 In my population. 23:36 I have a child and they need to go on full Anik acid 23:40 and maybe I'm working with a pediatrician or somebody who has 23:44 prescription rates and saying, will they prescribe full Anik acid? 23:48 And then they look at the parent like, I'm not going to prescribe your child 23:50 a chemotherapy drug. So that's one challenge. 23:53 The other challenge 23:54 is that we look over and that's available just through the regular pharmacy 23:59 a lot of times actually has dairy product in it has some lactose in it. 24:03 So it goes against what we're trying to accomplish 24:06 because we're also telling the family you have to remove dairy. 24:11 But yet we're then giving the medication that has it 24:13 that treats this condition and giving them dairy product with it. 24:18 So then the other option is to get it compounded and when you get it 24:22 compounded, it can be extremely expensive and it can range depending on the price 24:27 depending on which compounding pharmacy you're using. 24:30 And so there are some challenges here in regards to treatment. 24:33 Yeah. 24:34 Yes okay. 24:35 So how long does it take if someone is very diligent. 24:40 So let's say they remove dairy 100% from the diet 24:43 and they start taking the appropriate dose of volcanic acid. 24:47 In your experience, how long does it take before you start to see a change? 24:52 You know, it's a spectrum, right? 24:54 And so sometimes I'm amazed by how quickly I can see it. 24:57 Like I can see it by the next appointment, right. 25:00 Which might be eight weeks. 25:01 Or realistically, I think it's going to take at least three months. 25:05 The reason being is with dairy in the system, I think, you know, 25:08 the immune response to that can take some time to go down. 25:13 Right. 25:13 So I tell patients to realistically give it at least three months. 25:19 But it's surprising because a lot of people will see it before then. 25:23 And I think even in the research when they're looking, 25:25 say again at treatment resistant depression, 25:27 when they're looking at the trials, it's not very long trials. 25:30 It's still around that three month mark, like the 12 weeks that they're kind of 25:34 seeing what the improvements are. 25:36 So that's usually around the time. 25:38 However I do treat for longer than that though. 25:41 So just because you get, 25:42 you know, the results that you're looking for around, then I will continue to treat 25:47 for a minimum of a year, most of the time, depending on what the result is. 25:51 I will treat longer than that. Okay. 25:55 And is there anything that you would like to share from the study 25:58 that you were the lead author on? What? 26:00 Our audience. 26:01 Yeah. 26:01 So the the study that we published was the first in the population 26:05 for Pans and Pandas. 26:06 It was also looking at prevalence. 26:09 And so what we found was that 63.8%, almost 64% of children 26:15 who were in our, study group were positive for the cerebral folate deficiency
Treatment with high-dose folinic acid and dairy removal 26:20 due to having either the binding or the blocking autoantibodies. 26:24 What was so interesting about that, that the kids who were positive, 26:30 where we had some that had some overlapping comorbidity with autism, 26:36 and when we looked at the children with autism versus 26:39 the ones who had just pans and pandas, their levels were actually much higher 26:44 than the children with autism, 26:46 which is really fascinating being in my world and in my community, 26:49 because cerebral folate deficiency is so prevalent in children with autism. 26:54 So it's like, what does that mean that these children with pans 26:58 pandas have much higher levels than the children with autism? 27:02 It was just that that's interesting into question mark. 27:05 And I don't quite know. 27:06 But the other thing that was interesting is that those who had higher levels of, 27:11 for instance, the binding autoantibody, they were more likely to have tics. 27:16 And so this could be something that's, you know, more prevalent 27:20 maybe in the Tourette's population we don't quite know, or 27:23 the children who have childhood tick disorder, which is very common. 27:27 Are they the ones with the cerebral folate deficiency? 27:29 And is that then predisposing them possibly to having immune dysregulation. 27:35 And they could present with pans pandas down the line maybe I don't know. 27:40 So that was fascinating. 27:42 What we also found clinically is the children 27:46 who had cerebral folate deficiency when we treated them again 27:50 with the high dose splenic acid and took out the dairy, 27:52 they had significant improvements in their symptoms. 27:56 And so this was the OCD, 27:58 the anxiety, the tics, the depression 28:02 and what I'm most interested 28:04 in as well right now is looking at speech, this fluency. 28:08 So about 50% of children with pans will have some form of speech, just fluency. 28:13 So that could be stuttering, that could be mutism, that could be 28:17 putting in words and not really being able to get their thoughts out. 28:20 And I've had some cases in my office that those children 28:24 that present with that are positive for the cerebral folate deficiency. 28:28 And when we put in the high dose phonic 28:31 acid, for instance, the stutter completely resolved. 28:34 And so this is something that again, I just find 28:38 fascinating in the population for pans pandas. 28:42 And it really made me curious because my population really is 28:45 the ones that have underlying tick borne disease with pans pandas like, 28:49 how is this playing a role in tick borne disease and not just pans? 28:52 Pandas at that. 28:53 If you know and how this all comes together, 28:56 really the symptom relief that we can get these people, 28:59 regardless of the infection in the immune dysregulation because like you said, 29:03 even being able to bring down the anxiety, being able to bring down that brain fog 29:08 and helping with mental clarity could change somebody's life and regard 29:14 like their how they are able to get through and move through treatment. 29:18 I mean, it's just going to improve daily living significantly, right? 29:23 And if you look at all of the other actions of folic acid in the body too, 29:27 right, like you're right, like it could actually explain 29:31 why some cases of even if we just looked at Lyme as, 29:36 as that vector borne disease, why some patients can have such severe 29:41 neurological conditions even with neuropathy and things like that. 29:46 Right. 29:47 Versus, you know, somebody else. Yes. 29:50 Question. 29:51 Because I so this just popped into my head, I would imagine that 29:55 a lot of our listeners are experiencing the same. 29:58 So what's the harm in taking a high dose splenic 30:01 acid like is there are there potential side effects? 30:04 Is there a downside? 30:05 Is there a point where you know too much? 30:09 Is too much? 30:09 And what would that look like? 30:11 Talk us through that. Yeah. 30:13 So what can happen when you put too much phonic acid in too quickly? 30:17 Is there can be some side effects, mainly agitation and irritability. 30:22 That's the number one that I see. 30:24 And the second one is insomnia. 30:26 So in the literature they're also going to put aggression down. 30:29 But I don't see that clinically. 30:31 So it's the agitation irritability and insomnia. 30:34 Essentially what's happening is that your the neurotransmitters 30:38 are almost kind of like depleted from not having this folate in the brain. 30:42 Right. 30:43 And so all of a sudden you're flooding the system with that. 30:46 And what you're kind of overwhelming the synapses occurring at, 30:49 say serotonin, neurotransmitters the dopamine neurotransmitters. 30:54 And it can cause an increase in some of those symptoms. 30:58 Right. 30:59 And so that's when you go too fast and too much. 31:02 And so I think kind of staying in that weight dependent 31:06 range up to 50mg is very safe. 31:10 But it's how you go about implementing it. 31:14 That is what you need to watch. 31:16 So usually I start at much lower doses than what their weight 31:19 dependent dosage is and move slowly and at. 31:23 Sometimes I move faster than they think 31:25 some of my other colleagues like I'll keep going up every week, 31:29 and then if somebody has those symptoms, I just bring it back down 31:33 and hold there for, you know, two weeks before moving up again. 31:38 Right. 31:38 But sometimes then, like the literature, what they're saying is like, 31:41 you can go like every month kind of increase it up. 31:46 But my patients and my clients.com, you know, a lot of them are really suffering. 31:51 Right. 31:51 So I try to get them the released that I know is possible. 31:56 And a quicker time frame because I'm able to help them through. 32:01 Okay, you're experiencing this. 32:02 Let's back down and let's, you know, 32:04 try again at this time and kind of give them the instructions 32:07 again in the literature, what it's saying is that it is a very safe intervention. 32:11 And if you are suspecting this, that it might be worth doing a trial 32:16 of putting it in for a period of time without necessarily doing the testing. 32:21 Right. So you're saying you have a weight 32:24 dependent target dose that you want to reach. 32:28 Where would you start? Like how would you 32:32 derive your starting dose 32:35 and how many weeks do you typically like for the typical patient, 32:41 you know, do you take to achieve that target weight dependent dose. 32:46 So you're going to start at X and you're going to arrive at that target dose. 32:50 But like over how many weeks. 32:52 And you know do you do you double every week or two weeks. 32:55 Like how do you work up to it. Yeah. 32:57 So again it kind of depends on the person and how big they are, but usually like
Dosing, side effects, and closing advice 33:03 and how sensitive they are. That's another thing, right? 33:05 If you're somebody or your child is super sensitive, they react to everything. 33:09 You're going to want to start lower than what I'm going to say right now. 33:12 But I think 7.5mg is actually a pretty good place to start. 33:17 And so I'll do that for a week and then every week increase 33:20 it by 7.5mg up into the weight dependent. 33:24 Personally, I find 30mg to be like a sweet spot 33:28 a little bit for people and I'll see something around that time. 33:32 And if I'm seeing an improvement, 33:35 I will kind of go quicker to get to the end goal. 33:38 But you don't want to rule out that the intervention didn't work for you 33:41 unless you're kind of at that weight dependent dose for, 33:45 you know, as I said, a period of time, which minimum is going to be three months, 33:49 I really think it should be up to a year for a treatment there. 33:53 Okay. 33:53 All right. 33:54 Well, any last words of advice that you'd like to leave our listeners with? 33:58 I would love to keep talking, but we are pretty much out of time. 34:02 Okay. 34:03 Well, this has been wonderful, but I think the biggest thing is 34:06 this should be explored. 34:07 If you or your child are experiencing neuro psych symptoms associated 34:12 with vector borne diseases, this could be an additional piece 34:15 that's not necessarily infection driven, but perhaps there was a susceptibility 34:21 that occurred beforehand, or a dietary intervention 34:24 that you could implement to get relief for those symptoms. 34:28 And so there's still so much information that we need to figure out 34:33 regarding cerebral foye deficiency in this population. 34:36 But as I said, when looking at my data, it is very interesting and also promising 34:42 that this could be just a piece of the puzzle 34:45 that's occurring for you to get you relief 34:48 from these persistent symptoms that you're having just to make life 34:52 easier for you while you're navigating this vector borne disease. 34:57 And this illness. 34:58 And so I encourage people to explore further, and I wish more practitioners 35:03 also would be testing for this, because it can make a difference. 35:06 And the outcomes of treatment plans. 35:09 Yeah, absolutely. 35:11 So are you taking new patients? 35:13 I am taking new patients. 35:15 But there are listeners how to find you. 35:18 So you can go on to my website, which is Lindsay Wells Indeed.com. 35:24 And so all the information about my practice is there. 35:27 And you can also find me on Instagram, Lindsey Wells and 35:30 and I do love to post about vector borne diseases. 35:34 I love to post about Pans and Panda Cerebral folate deficiency. 35:39 And you can find more information there. 35:41 And you can also check out my paper that you know, I did write in regards 35:45 to the Pans Pandas population, and hopefully you'll see more coming out. 35:51 About cerebral folate 35:52 deficiency specifically for this population. 35:56 Awesome. 35:57 Any upcoming events you'd like to share? 35:59 This upcoming event that we have going on is the Lyme Healers Event. 36:03 This is a free online summit and it's focused on 36:06 women and children who have vector borne diseases. 36:10 This year, we're going to be focusing more on neuropsychiatric 36:13 manifestations of vector borne diseases. 36:16 But it's a free online event and you can sign up for free at line heal her, stop. 36:23 Awesome. Yeah. 36:25 And by the time this actually airs, that will have been over. 36:29 So you'll have to catch the replay. Yes. 36:31 Which will do you for that? Yes. 36:33 Sometime in the summer of, 2025 I guess by then. 36:37 So yes. 36:38 So we will definitely have an 36:39 encore going on, but you can always check out the recordings on the website. 36:43 Thank you for that, Mariah. 36:44 Yeah, absolutely. All right. 36:45 So thank you so much for being here, Lindsey, 36:48 and for all of our listeners at home. 36:50 Thank you for joining us. 36:52 And I truly hope that this helps you on your journey to healing Lyme. 36:57 Take care. We'll see you next time. Bye.
Comments